Additional file 1.

Figure S1. Type and scheduling of assessments during the 12-week study. Table S1. Baseline characteristics (intent-to-treat population). Figure S2. Most important benefit of the electronic autoinjection system as rated by patients at (a) Week 4, (b) Week 8 and (c) Week 12 (intent-to-treat population). IFN, interferon; im, intramuscular; sc, subcutaneous.

Format: DOC Size: 243KB Download file

This file can be viewed with: Microsoft Word Viewer

Lugaresi et al. BMC Neurology 2012 12:7   doi:10.1186/1471-2377-12-7